WO2007026038A3 - Use of a mycosporin-type amino acid (shinorine) as an antioxidant - Google Patents

Use of a mycosporin-type amino acid (shinorine) as an antioxidant Download PDF

Info

Publication number
WO2007026038A3
WO2007026038A3 PCT/ES2006/000492 ES2006000492W WO2007026038A3 WO 2007026038 A3 WO2007026038 A3 WO 2007026038A3 ES 2006000492 W ES2006000492 W ES 2006000492W WO 2007026038 A3 WO2007026038 A3 WO 2007026038A3
Authority
WO
WIPO (PCT)
Prior art keywords
shinorine
mycosporin
amino acid
antioxidant
type amino
Prior art date
Application number
PCT/ES2006/000492
Other languages
Spanish (es)
French (fr)
Other versions
WO2007026038A2 (en
Inventor
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Original Assignee
Univ Malaga
La Coba Luque Francisca De
Arjona Jose Aguilera
Figueroa Felix Lopez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Malaga, La Coba Luque Francisca De, Arjona Jose Aguilera, Figueroa Felix Lopez filed Critical Univ Malaga
Publication of WO2007026038A2 publication Critical patent/WO2007026038A2/en
Publication of WO2007026038A3 publication Critical patent/WO2007026038A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • A61K36/04Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9717Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9733Lichens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a mycosporin-type amino acid (shinorine) which can be used as an antioxidant and which is suitable for use in the biotechnological industry. The invention outlines the potential use of a mycosporin-type amino acid (MAA) as an antioxidant substance, specifically shinorine isolated from red alga Gymnogongrus devoniensis, and to the possible use thereof in pharmaceutical, nutraceutical or functional food preparations, among others, for the prevention of oxidative stress.
PCT/ES2006/000492 2005-08-31 2006-08-28 Use of a mycosporin-type amino acid (shinorine) as an antioxidant WO2007026038A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP200502157 2005-08-31
ES200502157A ES2284344B1 (en) 2005-08-31 2005-08-31 USE OF AMINO ACID TYPE MICOSPORINE (SHIMORINE) IN PRODUCTS FOR PREVENTION AND TREATMENT OF PARKINSON AND ALZHEIMER.

Publications (2)

Publication Number Publication Date
WO2007026038A2 WO2007026038A2 (en) 2007-03-08
WO2007026038A3 true WO2007026038A3 (en) 2007-05-24

Family

ID=37809233

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2006/000492 WO2007026038A2 (en) 2005-08-31 2006-08-28 Use of a mycosporin-type amino acid (shinorine) as an antioxidant

Country Status (2)

Country Link
ES (5) ES2301428B1 (en)
WO (1) WO2007026038A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169496A (en) * 2006-06-27 2019-04-15 Nutratec S R L Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803201A1 (en) * 1999-12-30 2001-07-06 Gelyma Algal extracts containing amino acid analogs of mycosporin are useful as dermatological protecting agents against ultraviolet radiation
WO2002039974A1 (en) * 2000-11-17 2002-05-23 Natural Environment Research Council Personal care compositions
EP1473028A1 (en) * 2003-04-30 2004-11-03 Mibelle AG Cosmetic skin care products and cosmetic agents for protecting skin against premature aging

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849346A (en) * 1981-09-18 1983-03-23 Mitsubishi Chem Ind Ltd Mycosporine-based amino acid and its derivative
FR2655268B1 (en) * 1989-12-06 1994-10-14 Secma USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS.
CA2251457A1 (en) * 1998-10-23 2000-04-23 Norman Huner Compositions including naturally occurring compounds from plants, algae and cyanobacteria for protection against solar radiation
EP1443898B1 (en) * 2001-11-14 2009-01-14 Larena Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells
FR2876004B1 (en) * 2004-10-01 2007-04-06 Exsymol Sa Monegasque USE OF RED ALGAE SUBJECTED TO EXTREME CONDITIONS OF TEMPERATURE AND BRIGHTNESS
FR2882894B1 (en) * 2005-03-11 2009-04-03 Larena Sa SUPPLETIVE FOOD COMPOSITION

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803201A1 (en) * 1999-12-30 2001-07-06 Gelyma Algal extracts containing amino acid analogs of mycosporin are useful as dermatological protecting agents against ultraviolet radiation
WO2002039974A1 (en) * 2000-11-17 2002-05-23 Natural Environment Research Council Personal care compositions
EP1473028A1 (en) * 2003-04-30 2004-11-03 Mibelle AG Cosmetic skin care products and cosmetic agents for protecting skin against premature aging

Also Published As

Publication number Publication date
ES2284344B1 (en) 2008-11-01
WO2007026038A2 (en) 2007-03-08
ES2301427A1 (en) 2008-06-16
ES2301425A1 (en) 2008-06-16
ES2301427B1 (en) 2009-05-01
ES2301428B1 (en) 2009-05-01
ES2284344A1 (en) 2007-11-01
ES2301428A1 (en) 2008-06-16
ES2301426B1 (en) 2009-05-01
ES2301426A1 (en) 2008-06-16
ES2301425B1 (en) 2009-05-01

Similar Documents

Publication Publication Date Title
WO2005082927A3 (en) Antihypertensive peptides
Hayes et al. Boarfish protein recovery using the pH-shift process and generation of protein hydrolysates with ACE-I and antihypertensive bioactivities in spontaneously hypertensive rats
WO2011100763A3 (en) Ruminant dietary supplement compositions and methods of manufacturing and using the same
Tantoush et al. Green tea catechins of food supplements facilitate pepsin digestion of major food allergens, but hampers their digestion if oxidized by phenol oxidase
WO2009017840A9 (en) Protein and isolated or purified amino acid product containing compositions and uses thereof
WO2003041679A3 (en) Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells
WO2007059715A8 (en) Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
WO2008036932A3 (en) Compositions and methods comprising boswellia species
WO2007079139A3 (en) Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
TW200744665A (en) Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2010069532A8 (en) Antibodies against human angiopoietin 2
IL196133A0 (en) Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same
WO2007016591A3 (en) Compositions and methods for monitoring and altering protein folding and solubility
WO2007141392A3 (en) Compositions comprising betulonic acid
HUP0400563A2 (en) Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate
CO2022006972A2 (en) Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins
IL186050A0 (en) Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
KR20130081231A (en) Soybean protein hydrolysate-containing antioxidant and use thereof
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
WO2007137297A3 (en) Foods and beverages with additives
WO2007125562A3 (en) Method for the preparation and use of an enriched cyanidine-s-o-beta-glucopyranoside extract and derivatives thereof from fruits and vegetables containing said anthocyanin and method for the purification and use of cyanidine-3-o-beta- glucopyranoside and derivatives thereof obtained
WO2006053882A3 (en) Benzothiazole formulations and use thereof
WO2007026035A3 (en) Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant
NZ585092A (en) Food material for inhibiting osteoclastogenesis
WO2008051448A3 (en) Methods and compositions for efficient removal of protein a from binding molecule preparations

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06807937

Country of ref document: EP

Kind code of ref document: A2